Cargando…
Blood eosinophils, fractional exhaled nitric oxide and the risk of asthma attacks in randomised controlled trials: protocol for a systemic review and control arm patient-level meta-analysis for clinical prediction modelling
INTRODUCTION: The reduction of the risk of asthma attacks is a major goal of guidelines. The fact that type-2 inflammatory biomarkers identify a higher risk, anti-inflammatory responsive phenotype is potentially relevant to this goal. We aim to quantify the relation between blood eosinophils, exhale...
Autores principales: | Couillard, Simon, Steyerberg, Ewout, Beasley, Richard, Pavord, Ian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8977743/ https://www.ncbi.nlm.nih.gov/pubmed/35365539 http://dx.doi.org/10.1136/bmjopen-2021-058215 |
Ejemplares similares
-
Derivation of a prototype asthma attack risk scale centred on blood eosinophils and exhaled nitric oxide
por: Couillard, Simon, et al.
Publicado: (2022) -
A randomised controlled trial of small particle inhaled steroids in refractory eosinophilic asthma (SPIRA)
por: Hodgson, David, et al.
Publicado: (2015) -
Fractional exhaled nitric oxide (FeNO): the future of asthma care?
por: Wang, Kay, et al.
Publicado: (2023) -
Evaluation of the diagnostic accuracy of fractional exhaled nitric oxide (FeNO) in patients with suspected asthma: study protocol for a prospective diagnostic study
por: Kellerer, Christina, et al.
Publicado: (2021) -
Association of elevated fractional exhaled nitric oxide concentration and blood eosinophil count with severe asthma exacerbations
por: Price, David B., et al.
Publicado: (2019)